Cargando…
Vitamin D3 attenuates SARS‐CoV‐2 nucleocapsid protein‐caused hyperinflammation by inactivating the NLRP3 inflammasome through the VDR‐BRCC3 signaling pathway in vitro and in vivo
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection‐caused coronavirus disease 2019 (COVID‐19) is a global crisis with no satisfactory therapies. Vitamin D3 (VD3) is considered a potential candidate for COVID‐19 treatment; however, little information is available regarding the exa...
Autores principales: | Chen, Mingliang, He, Ying, Hu, Xiaofeng, Dong, Xunhu, Yan, Zexuan, Zhao, Qingning, Li, Jingyuan, Xiang, Dongfang, Lin, Yong, Song, Hongbin, Bian, Xiuwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285036/ https://www.ncbi.nlm.nih.gov/pubmed/37361896 http://dx.doi.org/10.1002/mco2.318 |
Ejemplares similares
-
miR-369-3p Modulates Intestinal Inflammatory Response via BRCC3/NLRP3 Inflammasome Axis
por: Scalavino, Viviana, et al.
Publicado: (2023) -
Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation
por: Bonaventura, Aldo, et al.
Publicado: (2022) -
Vitamin D3 ameliorates nitrogen mustard‐induced cutaneous inflammation by inactivating the NLRP3 inflammasome through the SIRT3–SOD2–mtROS signaling pathway
por: Dong, Xunhu, et al.
Publicado: (2021) -
Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination
por: Rao, Zebing, et al.
Publicado: (2019) -
SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation
por: Pan, Pan, et al.
Publicado: (2021)